Sign Up
HB 653 Maryland House of Delegates · 2018 Regular Session

Health Care Providers - Opioid and Benzodiazepine Prescriptions - Discussion of Benefits and Risks

Bill status signed all 5 stages cleared
Introduction
Jan 2018
Committee Review
Apr 2018
House of Delegates Passage
Apr 2018
Senate Passage
Apr 2018
Signed into Law
Apr 2018
Introduced Jan 29, 2018 Signed Apr 24, 2018
Floor votes · Senate Apr 9, 2018 · House of Delegates Apr 4, 2018

How they voted

36–0
Passed · 1 other
Total votes 37
Apr 9, 2018
D Democratic27
26 Yea 1
96% Yea
R Republican10
10 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
16
Key actions
8
Committee
7
Apr 24, 2018
Signed into law
Approved by the Governor - Chapter 215
executive
Apr 10, 2018
Lower · Passed
Returned Passed
lower
Apr 9, 2018
Upper · Passed
Third Reading Passed (45-0)
upper
Apr 9, 2018
Upper · Passed
Favorable Report Adopted
upper
Apr 9, 2018
Upper · Passed
Favorable Report by Education, Health, and Environmental Affairs
upper
Apr 9, 2018
Committee
Rereferred to Education, Health, and Environmental Affairs
upper
Apr 5, 2018
Committee
First Reading Senate Rules
upper
Apr 4, 2018
Lower · Passed
Third Reading Passed (131-6)
lower
Apr 3, 2018
Lower · Passed
Favorable with Amendments {516289/1 Report Adopted
lower
Apr 3, 2018
Lower · Passed
Favorable with Amendments Report by Health and Government Operations
lower
Jan 29, 2018
Committee
First Reading Health and Government Operations
lower
0 primary · 20 co-sponsors

Sponsors

No sponsor information available.